Nuzenio

Pluvicto Approved Earlier

Pluvicto Approved Earlier news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 9 publisher sources 100/100 entity strength

Latest news

FDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA - Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center · Thu, 06 Aug 2026 04:00:00 GMT FDA Approves Pluvicto for Earlier Use in Prostate Cancer - SurvivorNetSurvivorNet · Tue, 04 Aug 2026 17:34:02 GMT FDA Approval Nearly Doubles Eligible Patient Pool For Novartis' Pluvicto - BenzingaBenzinga · Mon, 03 Aug 2026 16:56:48 GMT Pluvicto Approved Earlier in Metastatic Prostate Cancer - MedscapeMedscape · Mon, 03 Aug 2026 14:03:57 GMT Novartis' Pluvicto leaps ahead into earlier manifestation of prostate cancer - Fierce PharmaFierce Pharma · Mon, 03 Aug 2026 12:33:04 GMT Novartis’ Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer - PMLiVEPMLiVE · Mon, 03 Aug 2026 11:55:35 GMT Novartis (SWX:NOVN) Wins FDA Approval For Pluvicto In Earlier Prostate Cancer - Yahoo FinanceYahoo Finance · Sun, 02 Aug 2026 10:06:47 GMT Novartis wins FDA approval for Pluvicto in earlier-line PSMA+ prostate cancer - DealroomDealroom · Sat, 01 Aug 2026 09:20:02 GMT

Timeline

Thu, 06 Aug 2026 04:00:00 GMTFDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA - Memorial Sloan Kettering Cancer Center

Tue, 04 Aug 2026 17:34:02 GMTFDA Approves Pluvicto for Earlier Use in Prostate Cancer - SurvivorNet

Mon, 03 Aug 2026 16:56:48 GMTFDA Approval Nearly Doubles Eligible Patient Pool For Novartis' Pluvicto - Benzinga

Mon, 03 Aug 2026 14:03:57 GMTPluvicto Approved Earlier in Metastatic Prostate Cancer - Medscape

Mon, 03 Aug 2026 12:33:04 GMTNovartis' Pluvicto leaps ahead into earlier manifestation of prostate cancer - Fierce Pharma

Mon, 03 Aug 2026 11:55:35 GMTNovartis’ Pluvicto approved by FDA for metastatic hormone-sensitive prostate cancer - PMLiVE

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Pluvicto12 live mentions Novartis5 live mentions Metastatic Prostate Cancer4 live mentions FDA4 live mentions PSMA4 live mentions FDA Expands Approval3 live mentions Targets2 live mentions Protein Called PSMA2 live mentions Memorial Sloan Kettering2 live mentions Earlier Use2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pluvicto Approved Earlier.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.